Management

More documents

Recommendations

Info

Beeh, K.M., Hederer, B., Glaab, T., Muller, A., Rutten-van Mölken,M.P.M.H., Kesten, S. & Vogelmeier, C. (2009). Study designconsiderations in a large COPD trial comparing effects of tiotropiumwith salmeterol on exacerbations. International Journal of COPD, 4,119-125.Berghout, C.C., Zevalkink, J. & Hakkaart-van Roijen, L. (2010). A costutilityanalysis of psychoanalysis versus psychoanalytic psychotherapy.International Journal of Technology Assessment in Health Care, 26(1),3-10.Bijlenga, D., Birnie, E. & Bonsel, G.J. (2009). Feasibility, reliability, andvalidity of three health-state valuation methods using multipleoutcomevignettes on moderate-risk pregnancy at term. Value inHealth, 12(5), 821-827.Bleichrodt, H. & Pinto, J.L. (2009). New Evidence of PreferenceReversals in Health Utility Measurement. Health Economics, 18(6), 713-726.Bleichrodt, H. & Filko, M. (2010). A Reply to Gandjour and Gafni.Journal of Health Economics, 29, 329-331.Bobinac, A., Exel, N.J.A. van, Rutten, F.F.H. & Brouwer, W.B.F. (2010).Caring for and caring about: Disentangling the caregiver effect andthe family effect. Journal of Health Economics, 29, 549-556.Bobinac, A., Exel, N.J.A. van, Rutten, F.F.H. & Brouwer, W.B.F. (2010).Willingness to Pay for a Quality-Adjusted Life-Year: The IndividualPerspective. Value in Health, 13(8), 1049-1055.Boormans, E.M.A., Birnie, E., Bilardo, C.M., Oepkes, D., Bonsel, G.J. &Lith, J.M.M. van (2009). Karyotyping or rapid aneuploidy detection inprenatal diagnosis? The different views of users and providers ofprenatal care. Bjog-An International Journal of Obstetrics andGynaecology, 116(10), 1396-1399.Boormans, E.M., Birnie, E., Oepkes, D., Galjaard, R.J.H., Schuring-Blom,G.H. & Lith, J.M. van (2010). Comparison of Multiplex Ligation-Dependent Probe Amplification and Karyotyping in PrenatalDiagnosis. Bjog-An International Journal of Obstetrics andGynaecology, 115(2), 297-303.Boormans, E.M.A., Birnie, E., Knegt, A.C., Schuring-Blom, G.H., Bonsel,G.J. & Lith, J.M.M. van (2010). Aiming at multidisciplinary consensus:what should be detected in prenatal diagnosis? Prenatal Diagnosis, 30,1049-1056.Boormans, E.M.A., Birnie, E., Oepkes, D., Boekkooi, P.F., Bonsel, G.J. &Lith, J.M.M. van (2010). Individualized choice in prenatal diagnosis: theimpact of karyotyping and standalone rapid aneuploidy detection onquality of life. Prenatal Diagnosis, 30, 928-936.70
Boormans, E.M.A., Birnie, E., Oepkes, D., Bilardo, C.M., Wildschut,H.I.J., Creemers, J., Bonsel, G.J. & Lith, J.M.M. van (2010). The impact ofrapid aneuploidy detection (RAD) in addition to karyotyping versuskaryotyping on maternal quality of life. Prenatal Diagnosis, 30, 425-433.Boot, C.R.L., Exel, N.J.A. van & Gulden, J.W.J. van der (2009). "My LungDisease Won't Go Away, it's There to Stay": Profiles of Adaptation toFunctional Limitations in Workers with Asthma and COPD. Journal ofOccupational Rehabilitation, 3(13), 284-292.Bouwmans, C.A.M., Janssen, J., Huijgens, P. & Uyl de Groot, C.A.(2009). Costs of haematological adverse events in chronic myeloidleukaemia patients: a retrospective cost analysis of the treatment ofanaemia, neutropenia and thrombocytopenia in patients with chronicmyeloid leukaemia. Journal of Medical Economics, 12(2), 164-169.Brouwer, W.B.F., Grootenboer, S. & Sendi, P. (2009). The Incorporationof Income and Leisure in Health State Valuations When the Measure IsSilent: An Empirical Inquiry into the Sound of Silence. Medical DecisionMaking, 29, 503-512.Brouwer, W.B.F. & Rutten, F.F.H. (2010). The efficiency frontierapproach to economic evaluation: will it help German policy making?Health Economics, 19, 1128-1131.Buijsen, M.A.J.M. (2010). Autonomy, Human Dignity, and the Right tohealthcare: A Dutch Perspective. Cambridge Quarterly of HealthcareEthics, 19(3), 321-329.Christiaans, I., Langen, I.M. van, Birnie, E., Bonsel, G.J., Wilde, A.A.M.& Smets, E.M.A. (2009). Genetic Counseling and Cardiac Care inPredictively Tested Hypertrophic Cardiomyopathy Mutation Carriers:The Patiens' Perspective. American Journal of Medical Genetics Part A,149A, 1444-1451.Christiaans, I., Langen, I.M. van, Birnie, E., Bonsel, G.J., Wilde, A.A.M.& Smets, E.M.A. (2009). Quality of Life and Psychological Distress inHypertrophic Cardiomyopathy Mutation Carriers: A Cross-SectionalCohort Study. American Journal of Medical Genetics Part A, 149A,602-612.Christiaans, I., Kok, T.M., Langen, I.M. van, Birnie, E., Bonsel, G.J.,Wilde, A.A.M. & Smets, E.M.A. (2010). Obtaining insurance after DNAdiagnostics: a survey among hypertrophic cardiomyopathy mutationcarriers. European Journal of Human Genetics, 18, 251-253.Christiaans, I., Engelen, K. van, Langen, I.M. van, Birnie, E., Bonsel,G.J., Elliott, P. & Wilde, A.A.M. (2010). Risk stratification for suddencardiac death in hypertrophic cardiomyopathy: systematic review ofclinical risk markers. Europace, 12, 313-321.71
Page 1:
Institute of Health Policy & Manage
Page 4 and 5:
COLOPHONActivities report 2009-2010
Page 6 and 7:
1Ambitious andcommittedProf. Wilfri
Page 8 and 9:
- expressed in the CWTS score - is
Page 10 and 11:
2ResearchProf. Erik Schut, PhD, dir
Page 12 and 13:
health care domain in developing co
Page 14 and 15:
Competition and regulationin health
Page 16 and 17:
Research theme 1The introduction of
Page 18 and 19:
Quality and efficiencyin health car
Page 20 and 21:
Since its foundation in 1982, socio
Page 22 and 23: Management and organisationof healt
Page 24: INFORMATION AND COMMUNICATION TECHN
Page 27 and 28: esources and costs. This standardis
Page 29 and 30: Part of the HEFPA projectis, for ex
Page 31 and 32: also see organisationssuch as Kaise
Page 33 and 34: countries and Panama.Whereas in Eur
Page 35 and 36: health care organisations. Managers
Page 37 and 38: example, the education facilitating
Page 39 and 40: This project will continuein 2011 u
Page 41 and 42: Management. In 2009Trudie van Duin
Page 43 and 44: students graduating isgood, but the
Page 45 and 46: Course was organised forthe third t
Page 47 and 48: Since 2009, the Academyprovides yea
Page 49 and 50: developments in thecompensation sys
Page 51 and 52: knowledge. Apart from the office ro
Page 54 and 55: 5Facts and figuresEducation2008-200
Page 56 and 57: 6StaffxxxRESEARCH GROUP HEALTH ECON
Page 58 and 59: xxxRESEARCH GROUP HEALTHINSURANCERe
Page 61 and 62: 7 AcademicPublicationsPlease turn t
Page 63 and 64: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
Page 65 and 66: Exter, A.P. den (2010). Health Syst
Page 67 and 68: Hermans, H.E.G.M. & Buijsen, M.A.J.
Page 69 and 70: Noord, T.J.C. van (2010). Gezondhei
Page 71: Al, M.J., Hakkaart-van Roijen, L.,
Page 75 and 76: Dror, D.M., Putten, O. van & Koren,
Page 77 and 78: Hakkaart-van Roijen, L., Verboom, P
Page 79 and 80: Kippersluis, J.L.W. van, O'Donnell,
Page 81 and 82: Poel, E. van de & Speybroeck, N. (2
Page 83 and 84: Tromp, M., Eijsden, M. van, Ravelli
Page 85 and 86: Wyers, C.E., Breedveld, J.J.L., Rei
Page 87 and 88: Zuiderent, T. & Berg, M. (2010). Th
Page 89 and 90: Thunnissen, M.M., Duivenvoorden, H.
Page 91 and 92: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
Page 93 and 94: Hasman, A., Andersen, S.K., Klein,
Page 95 and 96: Pirnejad, H. (2009). Invited commen
Page 97 and 98: Wijngaarden, J.D.H. van, Weggelaar-
Page 99 and 100: Hout, E. van, Stibane, R., Frederik
Page 101 and 102: Stoopendaal, A.M.V. (2009). De zorg
Page 103 and 104: WORKING PAPERSWORKING PAPERSAttema,
show all

Management

Create successful ePaper yourself

Delete template?

Save as template?